H U : Appointment of Directors and Executive Officers of the Company and its Major Subsidiaries
April 22, 2022 at 02:29 am
Share
FOR IMMEDIATE RELEASE
Company name:
H.U. Group Holdings, Inc.
Representative:
Shigekazu Takeuchi, Director,
President and Group CEO
Securities code:
4544 Prime Market, Tokyo
Stock Exchange
Appointment of Directors and Executive Officers of the Company and its Major Subsidiaries
Tokyo, Japan, April 22, 2022 --- H.U. Group Holdings, Inc. today announced the following appointment of directors and executive officers of the company and its major subsidiaries, with the decision at the meeting of the Board of Directors held on April 22, 2022. The appointment of directors and executive officers is scheduled to be effective as of June 21, 2022, following the General Shareholder's Meeting and the meeting of the Board of Directors.
1.H.U. Group Holdings, Inc.
(1)Candidates for Directors
Name
New title
Current title
Change
Shigekazu Takeuchi
Director
Director
Reappointment
Naoki Kitamura
Director
Director
Reappointment
Shigehiro Aoyama
Outside Director
Outside Director
Reappointment
Futomichi Amano
Outside Director
Outside Director
Reappointment
Ryoji Itoh
Outside Director
Outside Director
Reappointment
Moegi Shirakawa
Outside Director
-
New appointment
Keiji Miyakawa
Outside Director
Outside Director
Reappointment
Susumu Yamauchi
Outside Director
Outside Director
Reappointment
(2)Retiring Director
Name
New title
Current title
Eriko Matsuno
-
Outside Director
(3)Name and brief personal profile of the new Director
Name Moegi Shirakawa
Date of birth January 14, 1979
Profile Oct. 2003 Admitted to bar Joined Anderson Mori & Tomotsune (former Tomotsune & Kimura)
Sep.
2008
Associated with Sullivan & Cromwell LLP, New York
Aug.
2009
Rejoined Anderson Mori & Tomotsune
Jan.
2013
Partner of Anderson Mori & Tomotsune (incumbent)
Feb.
2021
Member of the Business Accounting Council of the Financial Services
Note: The appointment of Directors is scheduled to be effective as of June 21, 2022, following the General Shareholder's Meeting and the meeting of the Board of Directors.
3.Fujirebio Holdings, Inc.
(1)Candidates for Directors
Name
New title
Current title
Change
Goki Ishikawa
President and CEO
President and CEO
Reappointment
Takeshi Fujita
Director
Director
Reappointment
Monte Wiltse
Director
Director
Reappointment
Christiaan De Wilde
Director
Director
Reappointment
Shigekazu Takeuchi
Director
Director
Reappointment
Naoki Kitamura
Director
Director
Reappointment
Atsuko Murakami
Director
Director
Reappointment
Note: The appointment of Directors is scheduled to be effective as of June 21, 2022, following the General Shareholder's Meeting and the meeting of the Board of Directors.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Miraca Holdings Inc. published this content on 22 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 April 2022 06:27:02 UTC.
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.